Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum

scientific article published on December 1993

Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode1993PNAS...9011277S
P356DOI10.1073/PNAS.90.23.11277
P932PMC publication ID47965
P698PubMed publication ID8248241
P5875ResearchGate publication ID14951532

P50authorPaul GreengardQ309979
Tomas HökfeltQ2440397
Ole Petter OttersenQ7085927
P2093author name stringG L Snyder
V Gundersen
G Fisone
P Morino
P2860cites workProtein measurement with the Folin phenol reagentQ20900776
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applicationsQ24561689
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slicesQ28236649
DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1Q28259380
Evidence that type A CCK receptors facilitate dopamine efflux in rat brainQ68021750
Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistryQ69752487
The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassayQ70755496
Brain peptides as neurotransmittersQ72614435
Cholecystokinins in the central nervous system and neurohypophysisQ72934000
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brainQ28265789
Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokininQ28274708
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activityQ28334293
Distinct cholecystokinin receptors in brain and pancreasQ28366068
A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regionsQ28643908
Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolismQ34054730
Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus.Q36174208
Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the enzymeQ37647401
Quantitative electron microscopic immunocytochemistry of neuroactive amino acidsQ38364992
Immunochemical evidence of cholecystokinin-like peptides in brainQ39414097
Peptidergic neuronesQ40097706
Amino acids in rat neostriatum: Alteration by kainic acid lesionQ41026531
Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvementQ42204001
Metabolism and transport of amino acids studied by immunocytochemistryQ42503723
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distributionQ42524859
An electron microscopic, immunogold analysis of glutamate and glutamine in terminals of rat spinocerebellar fibersQ44254270
The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiationQ44337992
Characterization of antisera to glutamate and aspartateQ48162017
Selective degeneration of two out of the nine types of synapses in cat caudate nucleus after cortical lesionsQ48218279
Striatal lesions and transplants demonstrate that cholecystokinin receptors are localized on intrinsic striatal neurones: a quantitative autoradiographic studyQ48227676
Interactions between dopamine and amino acid-induced excitation and inhibition in the striatumQ48334305
Immunohistochemical evidence for a crossed cholecystokinin corticostriatal pathway in the rat.Q48395241
New peptide in the vertebrate CNS reacting with antigastrin antibodiesQ48435369
Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamineQ48449212
Studies on cholecystokinin-containing neuronal pathways in rat cerebral cortex and striatumQ48570559
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization.Q48691508
Effect of cholecystokinin octapeptide on endogenous amino acid release from the rat ventromedial nucleus of the hypothalamus and striatumQ48750236
Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanismsQ48784606
Cortical neurons expressing the cholecystokinin gene in the rat: distribution in the adult brain, ontogeny, and some of their projectionsQ48887576
Origin of the cholecystokinin-containing fibers in the rat caudatoputamenQ49019094
MORFOREL, a computer program for two-dimensional analysis of micrographs of biological specimens, with emphasis on immunogold preparationsQ49162061
The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampusQ54538986
P433issue23
P407language of work or nameEnglishQ1860
P921main subjectphosphorylationQ242736
cholecystokininQ60315441
P304page(s)11277-11281
P577publication date1993-12-01
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleRegulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum
P478volume90

Reverse relations

cites work (P2860)
Q33703262Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade
Q48617260Bidirectional regulation of DARPP-32 phosphorylation by dopamine.
Q48678036Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium spiny neurons: studies in vivo and in vitro
Q45020754Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach
Q48120764Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation
Q60050266Cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-d-aspartate antagonists phencyclidine and dizocilpine maleate
Q35639141DARPP-32: an integrator of neurotransmission
Q42989363Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons
Q48849175Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis
Q48414498Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats.
Q28583839Immunohistochemical characterization of cholecystokinin containing neurons in the rat basolateral amygdala
Q31031335Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons
Q48388865Modulation of the voltage-gated sodium current in rat striatal neurons by DARPP-32, an inhibitor of protein phosphatase
Q82029336Neurochemistry of Parkinson's disease
Q35104448Some aspects on the anatomy and function of central cholecystokinin systems
Q58112339The DARPP-32/protein phosphatase-1 cascade: a model for signal integration1Published on the World Wide Web on 22 January 1998.1
Q34100272The neurobiology of slow synaptic transmission

Search more.